Healthcare - Biotechnology - NASDAQ - US
$ 1.84
-3.16 %
$ 138 M
Market Cap
-2.09
P/E
INCOME STATEMENT
0
REVENUE
-25.1 M
OPERATING INCOME
-24 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Context Therapeutics Inc.
| Revenue | 0 |
| Cost Of Revenue | 12 K |
| Gross Profit | -12 K |
| Operating Expenses | 25.1 M |
| Operating Income | -25.1 M |
| Other Expenses | -1.11 M |
| Net Income | -24 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 12 K | 9.27 K | 0 | 0 | 0 |
| Gross Profit | 12 K | 9.27 K | 0 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 25.1 | 14.9 | 7.4 | 2.6 | 5.4 |
| Selling, General and Administrative Expenses | 7.3 | 7.8 | 3.6 | 0.9 | 3.0 |
| Research and Development Expenses | 17.8 | 7.1 | 3.8 | 1.6 | 2.4 |
| Operating Income | (25.1) | (15.4) | (10.5) | (2.6) | (5.4) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0.5 | 64.2 K | 0.7 | 1.1 |
| Total Other Income | 1.1 | 0.5 | 68.9 K | 9.2 | (1.0) |
| Pre-Tax Income | (24.0) | (14.8) | (10.5) | 6.6 | (6.4) |
| NET INCOME | |||||
| Tax Provision | 0 | (0.5) | (3.0) | 0.7 | 1.1 |
| Net Income | (24.0) | (14.3) | (7.4) | 6.6 | (7.5) |
| EPS | 1.5 | 0.9 | 0.47 | 0.61 | 0.68 |